Literature DB >> 1684905

Serotonin initiation of delayed-type hypersensitivity: mediation by a primitive Thy-1+ antigen-specific clone or by specific monoclonal IgE antibody.

P W Askenase1, W R Herzog, I Millet, V Paliwal, R Ramabhadran, C Rochester, G P Geba, W Ptak.   

Abstract

Elicitation of delayed-type hypersensitivity (DTH) responses is due to the required sequential action of two different antigen (Ag)-specific Thy-1+ cells: early acting, DTH-initiating cells and locally recruited CD4+, alpha beta-TCR+, DTH effector T cells. DTH-initiating cells have an unusual phenotype for Ag-specific cells (Thy-1+, CD5+, CD4-, CD8-, CD3-, sIg-, B220+ (CD45RA+), Mac 1+, IL-2R- and IL-3R+) and act by producing Ag-specific non-IgE factors that sensitize mast cells for release of the vasoactive amine serotonin (5HT) at the local site of elicitation of DTH by challenge. Another mechanism of DTH initiation involves Ag-specific IgE antibodies that also can sensitize mast cells for local serotonin release. Serotonin initiates DTH by activating the local endothelial cells to allow recruitment of DTH effector T cells, and also by activating 5HT-2 receptors on these recruited T cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684905     DOI: 10.1159/000210981

Source DB:  PubMed          Journal:  Skin Pharmacol        ISSN: 1011-0283


  9 in total

1.  Enteric neuronal density contributes to the severity of intestinal inflammation.

Authors:  Kara Gross Margolis; Korey Stevanovic; Nima Karamooz; Zi Shan Li; Ankur Ahuja; Fabien D'Autréaux; Virginia Saurman; Alcmene Chalazonitis; Michael David Gershon
Journal:  Gastroenterology       Date:  2011-04-28       Impact factor: 22.682

2.  Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity.

Authors:  G P Geba; W Ptak; P W Askenase
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

3.  Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter.

Authors:  S Haub; Y Ritze; I Bergheim; O Pabst; M D Gershon; S C Bischoff
Journal:  Neurogastroenterol Motil       Date:  2010-03-08       Impact factor: 3.598

Review 4.  Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.

Authors:  Natalie Terry; Kara Gross Margolis
Journal:  Handb Exp Pharmacol       Date:  2017

Review 5.  Hyperserotoninemia and altered immunity in autism.

Authors:  Nancy K Burgess; Thayne L Sweeten; William M McMahon; Robert S Fujinami
Journal:  J Autism Dev Disord       Date:  2006-07

Review 6.  Enteric Neuronal Regulation of Intestinal Inflammation.

Authors:  Kara Gross Margolis; Michael D Gershon
Journal:  Trends Neurosci       Date:  2016-07-20       Impact factor: 13.837

7.  Novel identified receptors on mast cells.

Authors:  Helena Migalovich-Sheikhet; Sheli Friedman; David Mankuta; Francesca Levi-Schaffer
Journal:  Front Immunol       Date:  2012-08-02       Impact factor: 7.561

8.  A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children.

Authors:  Gehan Ahmed Mostafa; Laila Yousef Al-Ayadhi
Journal:  J Neuroinflammation       Date:  2011-06-22       Impact factor: 8.322

Review 9.  The Effects of Serotonin in Immune Cells.

Authors:  Nadine Herr; Christoph Bode; Daniel Duerschmied
Journal:  Front Cardiovasc Med       Date:  2017-07-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.